Short term heart rate variability is preserved in Parkinson's disease under atomoxetine
This study demonstrates that a single dose of atomoxetine preserves short-term heart rate variability in Parkinson's disease patients, supporting its cardiovascular safety and viability as a treatment for neuropsychiatric symptoms.